1. Home
  2. BCYC vs DDL Comparison

BCYC vs DDL Comparison

Compare BCYC & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • DDL
  • Stock Information
  • Founded
  • BCYC 2009
  • DDL 2014
  • Country
  • BCYC United Kingdom
  • DDL China
  • Employees
  • BCYC N/A
  • DDL N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • BCYC Health Care
  • DDL Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • DDL Nasdaq
  • Market Cap
  • BCYC 566.5M
  • DDL 457.4M
  • IPO Year
  • BCYC 2019
  • DDL 2021
  • Fundamental
  • Price
  • BCYC $7.44
  • DDL $2.06
  • Analyst Decision
  • BCYC Buy
  • DDL
  • Analyst Count
  • BCYC 10
  • DDL 0
  • Target Price
  • BCYC $25.00
  • DDL N/A
  • AVG Volume (30 Days)
  • BCYC 274.8K
  • DDL 442.7K
  • Earning Date
  • BCYC 08-05-2025
  • DDL 08-06-2025
  • Dividend Yield
  • BCYC N/A
  • DDL N/A
  • EPS Growth
  • BCYC N/A
  • DDL N/A
  • EPS
  • BCYC N/A
  • DDL 0.18
  • Revenue
  • BCYC $25,722,000.00
  • DDL $3,241,404,122.00
  • Revenue This Year
  • BCYC $7.35
  • DDL $8.80
  • Revenue Next Year
  • BCYC N/A
  • DDL $11.75
  • P/E Ratio
  • BCYC N/A
  • DDL $11.24
  • Revenue Growth
  • BCYC N/A
  • DDL 17.62
  • 52 Week Low
  • BCYC $6.10
  • DDL $1.62
  • 52 Week High
  • BCYC $28.67
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 44.12
  • DDL 45.55
  • Support Level
  • BCYC $6.87
  • DDL $1.99
  • Resistance Level
  • BCYC $7.59
  • DDL $2.29
  • Average True Range (ATR)
  • BCYC 0.46
  • DDL 0.08
  • MACD
  • BCYC -0.06
  • DDL 0.01
  • Stochastic Oscillator
  • BCYC 29.69
  • DDL 21.67

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: